Learning Objectives: List ways single nicotine patch sales & prescription protocols boost access to treatment
Abstract:
Problem/Objective: Access to tobacco dependence treatment is often limited by cost and lack of insurance coverage. Nicotine patches are sold only in one or two week supplies, with a higher initial cost than tobacco. We sought to lower the cost barrier by selling single nicotine patches, and establishing a protocol for dispensing of prescription nicotine medications (inhaler, nasal spray) and bupropion (Zyban/Wellbutrin) by trained pharmacists.
Methods: We began a pilot project of selling single nicotine patches at a participating pharmacy, by prescription, to lower the initial cost of the patch. We have also begun a prescription protocol involving the pharmacy and a prescribing physician, to make prescription nicotine medications and bupropion available without the cost barrier of a physician office visit.
Results: With availability of single nicotine patches for $3.50 and prescriptive authority for nicotine medications and bupropion, the cost barrier has been lowered, allowing tobacco users to obtain tobacco dependence treatment at a local pharmacy at lower cost.
Conclusions: Sale of single nicotine patches should be made available more widely, and prescription protocols instituted, where allowed by state pharmacy guidelines. Reducing cost barriers improves access to tobacco dependence treatment.
Back to Poster Session
Back to Cessation, Nicotine, and the Science of Addiction
Back to The 2003 National Conference on Tobacco or Health (December 10-12, 2003)